Christopher Gibson - 05 Jun 2026 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Reporting relationship: Director
Issuer ticker: RXRX
Reported as of: 05 Jun 2026
Net transaction value: -$144,800
SEC form: 4
Accepted by SEC: 05 Jun 2026, 17:03:03 UTC
Prior SEC filing: 04 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/Jonathan Golightly, attorney-in-fact

Key filing fact

Christopher Gibson filed Form 4 for RECURSION PHARMACEUTICALS, INC. (RXRX) on 05 Jun 2026.

Key facts

This page summarizes Christopher Gibson's Form 4 filing for RECURSION PHARMACEUTICALS, INC. (RXRX).
3 reported transactions and 10 derivative rows are listed below.
Accepted by SEC: 05 Jun 2026, 17:03.

Change

Previous filing in this sequence was filed on 04 Jun 2026.
Current net transaction value: -$144,800.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001856369 Primary reporting owner

Gibson Christopher

Relationship: Director
Address: C/O RECURSION PHARMACEUTICALS, 41 S. RIO GRANDE STREET, SALT LAKE CITY
Signature: /s/Jonathan Golightly, attorney-in-fact
Signature date: 05 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RXRX transaction

Class A Common Stock

Conversion of derivative security

Transaction value
Shares: +40,000
Change %: +4.5%
Price: $0.000000^*
Shares after: 923,735
Date: 05 Jun 2026
Ownership: Direct
Footnotes: F1, F2

RXRX transaction

Class A Common Stock

Sale

Transaction value: $144,800
Shares: -40,000
Change %: -4.3%
Price: $3.62
Shares after: 883,735
Date: 05 Jun 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RXRX transaction Derivative

Class B Common Stock

Conversion of derivative security

Transaction value
Shares: -40,000
Change %: -0.93%
Price: $0.000000^*
Shares after: 4,263,334
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 40,000
Exercise price: $0.000000
Footnotes: F1, F2, F3

RXRX holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 386,000
Date: 05 Jun 2026
Ownership: by LAHWRAN-3 LLC
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $0.000000
Footnotes: F3, F4

RXRX holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 388,000
Date: 05 Jun 2026
Ownership: by LAHWRAN-4 LLC
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $0.000000
Footnotes: F3, F5

RXRX holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 50,000
Date: 05 Jun 2026
Ownership: by Gibson Family Trust
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $0.000000
Footnotes: F3, F6

RXRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,050,567
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $7.25
Footnotes: F7

RXRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 666,898
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $10.09
Footnotes: F8

RXRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 813,600
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $8.55
Footnotes: F9

RXRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 399,002
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $11.40
Footnotes: F10

RXRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,436
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $11.40

RXRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 282,500
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 0
Exercise price: $2.48
Footnotes: F11

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 11 footnotes

Footnote F1

Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person. Each share of Class B Common Stock is convertible into one share of Class A Common Stock.

Footnote F2

This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.

Footnote F3

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Footnote F4

The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.

Footnote F5

The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.

Footnote F6

The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.

Footnote F7

The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.

Footnote F8

The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.

Footnote F9

The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.

Footnote F10

The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.

Footnote F11

The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .